Market revenue in 2023 | USD 6.2 million |
Market revenue in 2030 | USD 10.4 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Echocardiography |
Fastest growing segment | Radionuclide cardiac imaging |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radionuclide cardiac imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging |
Key market players worldwide | Toshiba Corporation, Hologic Inc, Carestream Health - HCIS business, GE HealthCare Technologies Inc Common Stock, Siemens Healthineers AG ADR, Koninklijke Philips NV, Hitachi Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive coronary imaging market will help companies and investors design strategic landscapes.
Echocardiography was the largest segment with a revenue share of 30.65% in 2023. Horizon Databook has segmented the Japan non-invasive coronary imaging market based on radionuclide cardiac imaging, echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging covering the revenue growth of each sub-segment from 2018 to 2030.
In Japan, the healthcare sector is renowned for its adoption of cutting-edge medical technologies. The advancements in the non-PVC IV bags depends on their design, materials, and manufacturing techniques.
The competition is largely influenced by major pharmaceutical and healthcare corporations, along with specialized medical device manufacturers. The non-PVC IV bags market in Japan is competitive, with the presence of well-established industry leaders and emerging players.
Some of the companies operating in Japan non-PVC IV bags market are Baxter, B. Braun SE, Pfizer, Otsuka Pharmaceutical Co., Ltd., and KRATON CORPORATION. These companies offer a wide range of products and compete based on factors such as product quality, innovation, pricing, & distribution networks.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan non-invasive coronary imaging market , including forecasts for subscribers. This country databook contains high-level insights into Japan non-invasive coronary imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account